Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML
- PMID: 12476300
- DOI: 10.1038/sj.onc.1206081
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
